Shopping Cart 0
Cart Subtotal
AED 0

Anteo Diagnostics Ltd (ADO) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinical diagnostic, and medical device markets, including a PoC test for the diagnosis of heart attacks (troponin test). It holds patents for nanometre-thin primers, binders, and coatings. Anteo Diagnostics's patented nanoglue technology, Mix&Go, finds application in healthcare industry. The company is also investigating its nanoglue technology for attaching bio-molecules to synthetic surfaces and evaluating its potential in the manufacture of batteries. It has subsidiaries in Australia, Belgium and Spain. Anteo Diagnostics is headquartered in Brisbane, Queensland, Australia.

Anteo Diagnostics Ltd (ADO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Anteo Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Anteo Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Anteo Diagnostics Ltd, Medical Equipment, Deal Details 11

Private Equity 11

Bergen Global Opportunity Fund Invests USD1.5 Million in Anteo Diagnostics 11

Partnerships 12

Anteo Diagnostics Enters Into Licensing Agreement With eBioscience For Mix&Go Technology 12

Anteo Diagnostics Partners with Atomo Diagnostics 13

Anteo Diagnostics Enters Into Distribution Agreement With Gennova Scientific For Mix&Go 14

Equity Offering 15

Anteo Diagnostics Raises USD1 Million in Third Tranche of Private Placement of Shares 15

Anteo Diagnostics to Raise USD8.6 Million in Rights Offering of Shares 16

Anteo Diagnostics Completes Private Placement Of Shares For USD 5 Million 17

Debt Offering 18

Anteo Diagnostics to Raise USD10.6 Million in Private Placement of 10% Notes 18

Acquisition 19

Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 19

Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 20

Anteo Diagnostics Ltd-Key Competitors 21

Anteo Diagnostics Ltd-Key Employees 22

Anteo Diagnostics Ltd-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Financial Announcements 24

Aug 31, 2018: Anteo Diagnostics: 30 June 2018 unaudited preliminary financial statements 24

Sep 01, 2017: Anteo Diagnostics: 30 June 2017 Preliminary Financial Statements 25

Apr 28, 2017: Anteo Diagnostics: Quarterly Activities Report 26

Corporate Communications 29

Sep 10, 2018: Anteo Diagnostics: Appointment of chief executive officer 29

Apr 09, 2018: Anteo Diagnostics: CEO Resignation and CEO Appointment 30

Apr 03, 2018: Anteo Diagnostics: Chairman Appointed and Board Changes 31

Dec 06, 2017: Anteo Diagnostics: Appointment of Chief Executive Officer 32

Sep 01, 2017: Management changes resulting from sale of DIAsource 33

Product News 34

Jan 12, 2017: Anteo Diagnostics Strengthening its Intellectual Property Position in Medical Device Arena 34

Other Significant Developments 35

Jul 30, 2018: Anteo Diagnostics: Activities report-Quarter ended 30 June 2018 35

Apr 27, 2018: Anteo Diagnostics: Activities Report-Quarter Ended 31 March 2018 38

Jan 31, 2018: Activities Report-Quarter Ended 31 December 2017 40

Oct 31, 2017: Anteo Diagnostics: Activities Report-Quarter Ended 30 September 2017 42

Jan 31, 2017: Anteo Diagnostics: Quarter Ended 31 December 2016 45

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

Anteo Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Anteo Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Anteo Diagnostics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Anteo Diagnostics Ltd, Medical Equipment, Key Facts, 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Anteo Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Anteo Diagnostics Ltd, Deals By Market, 2012 to YTD 2018 9

Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Bergen Global Opportunity Fund Invests USD1.5 Million in Anteo Diagnostics 11

Anteo Diagnostics Enters Into Licensing Agreement With eBioscience For Mix&Go Technology 12

Anteo Diagnostics Partners with Atomo Diagnostics 13

Anteo Diagnostics Enters Into Distribution Agreement With Gennova Scientific For Mix&Go 14

Anteo Diagnostics Raises USD1 Million in Third Tranche of Private Placement of Shares 15

Anteo Diagnostics to Raise USD8.6 Million in Rights Offering of Shares 16

Anteo Diagnostics Completes Private Placement Of Shares For USD 5 Million 17

Anteo Diagnostics to Raise USD10.6 Million in Private Placement of 10% Notes 18

Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 19

Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 20

Anteo Diagnostics Ltd, Key Competitors 21

Anteo Diagnostics Ltd, Key Employees 22

Anteo Diagnostics Ltd, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Anteo Diagnostics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinical diagnostic, and medical device markets, including a PoC test for the diagnosis of heart attacks (troponin test). It holds patents for nanometre-thin primers, binders, and coatings. Anteo Diagnostics's patented nanoglue technology, Mix&Go, finds application in healthcare industry. The company is also investigating its nanoglue technology for attaching bio-molecules to synthetic surfaces and evaluating its potential in the manufacture of batteries. It has subsidiaries in Australia, Belgium and Spain. Anteo Diagnostics is headquartered in Brisbane, Queensland, Australia.

Anteo Diagnostics Ltd (ADO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Anteo Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Anteo Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Anteo Diagnostics Ltd, Medical Equipment, Deal Details 11

Private Equity 11

Bergen Global Opportunity Fund Invests USD1.5 Million in Anteo Diagnostics 11

Partnerships 12

Anteo Diagnostics Enters Into Licensing Agreement With eBioscience For Mix&Go Technology 12

Anteo Diagnostics Partners with Atomo Diagnostics 13

Anteo Diagnostics Enters Into Distribution Agreement With Gennova Scientific For Mix&Go 14

Equity Offering 15

Anteo Diagnostics Raises USD1 Million in Third Tranche of Private Placement of Shares 15

Anteo Diagnostics to Raise USD8.6 Million in Rights Offering of Shares 16

Anteo Diagnostics Completes Private Placement Of Shares For USD 5 Million 17

Debt Offering 18

Anteo Diagnostics to Raise USD10.6 Million in Private Placement of 10% Notes 18

Acquisition 19

Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 19

Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 20

Anteo Diagnostics Ltd-Key Competitors 21

Anteo Diagnostics Ltd-Key Employees 22

Anteo Diagnostics Ltd-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Financial Announcements 24

Aug 31, 2018: Anteo Diagnostics: 30 June 2018 unaudited preliminary financial statements 24

Sep 01, 2017: Anteo Diagnostics: 30 June 2017 Preliminary Financial Statements 25

Apr 28, 2017: Anteo Diagnostics: Quarterly Activities Report 26

Corporate Communications 29

Sep 10, 2018: Anteo Diagnostics: Appointment of chief executive officer 29

Apr 09, 2018: Anteo Diagnostics: CEO Resignation and CEO Appointment 30

Apr 03, 2018: Anteo Diagnostics: Chairman Appointed and Board Changes 31

Dec 06, 2017: Anteo Diagnostics: Appointment of Chief Executive Officer 32

Sep 01, 2017: Management changes resulting from sale of DIAsource 33

Product News 34

Jan 12, 2017: Anteo Diagnostics Strengthening its Intellectual Property Position in Medical Device Arena 34

Other Significant Developments 35

Jul 30, 2018: Anteo Diagnostics: Activities report-Quarter ended 30 June 2018 35

Apr 27, 2018: Anteo Diagnostics: Activities Report-Quarter Ended 31 March 2018 38

Jan 31, 2018: Activities Report-Quarter Ended 31 December 2017 40

Oct 31, 2017: Anteo Diagnostics: Activities Report-Quarter Ended 30 September 2017 42

Jan 31, 2017: Anteo Diagnostics: Quarter Ended 31 December 2016 45

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

Anteo Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Anteo Diagnostics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Anteo Diagnostics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Anteo Diagnostics Ltd, Medical Equipment, Key Facts, 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Anteo Diagnostics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Anteo Diagnostics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Anteo Diagnostics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Anteo Diagnostics Ltd, Deals By Market, 2012 to YTD 2018 9

Anteo Diagnostics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Bergen Global Opportunity Fund Invests USD1.5 Million in Anteo Diagnostics 11

Anteo Diagnostics Enters Into Licensing Agreement With eBioscience For Mix&Go Technology 12

Anteo Diagnostics Partners with Atomo Diagnostics 13

Anteo Diagnostics Enters Into Distribution Agreement With Gennova Scientific For Mix&Go 14

Anteo Diagnostics Raises USD1 Million in Third Tranche of Private Placement of Shares 15

Anteo Diagnostics to Raise USD8.6 Million in Rights Offering of Shares 16

Anteo Diagnostics Completes Private Placement Of Shares For USD 5 Million 17

Anteo Diagnostics to Raise USD10.6 Million in Private Placement of 10% Notes 18

Anteo Diagnostics Sells DIAsource to BioVendor for USD19 Million 19

Anteo Diagnostics Completes Acquisition of DIAsource for USD16.7 Million 20

Anteo Diagnostics Ltd, Key Competitors 21

Anteo Diagnostics Ltd, Key Employees 22

Anteo Diagnostics Ltd, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Anteo Diagnostics Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.